The largest database of trusted experimental protocols

Pmir report firefly luciferase reporter vector

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PMIR-REPORT Firefly Luciferase reporter vector is a plasmid DNA construct that expresses the firefly luciferase gene under the control of a specific promoter or regulatory sequence. The firefly luciferase gene serves as a reporter for gene expression and can be used to quantify the activity of the promoter or regulatory sequence of interest.

Automatically generated - may contain errors

6 protocols using pmir report firefly luciferase reporter vector

1

Functional Analysis of miR-526b and miR-1248

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the functional analysis of miR-526b and miR-1248, partial segments of the 3′ UTR of MMP1 mRNA containing the predicted miR-526b- & miR-1248-binding sequences were amplified with PCR using the following primer set flanking the SpeI and HindIII restriction enzyme sites: for the wild type, CTAGACTAGTTTTGAATGGAAAACACATGGTG, CCCAAGCTTAAACAAGGTTGACTTTATTCCAAA. The PCR products were cloned into the pMIR-REPORT Firefly Luciferase reporter vector (Ambion, Austin, TX, USA). Site-directed mutagenesis was performed by overlapping PCR using the following primers: TTGCCGGAGGAAAAGCAGCTCCCTCACACATGTGCAGTCACTGG, CCAGTGACTGCACATGTGTGAGGGAGCTGCTTTTCCTCCGGCAA (the mutated sequences are underlined.)
+ Open protocol
+ Expand
2

Constructing miR-7-5p target reporter plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Construction of the miR-7-5p perfect target reporter has been described previously [68 (link)]. Full-length wild-type (WT) and mutant (MT) RelA 3′-UTR reporter plasmids were synthesized by GenScript Inc. (Piscataway, NJ) to include the full length RelA 3′-UTR (nt 1919-2700 of GenBankTM accession number NM_021975) within the pmiR-REPORT firefly luciferase reporter vector (Ambion). Modifications were made to the RelA 3′-UTR at predicted miR-7-5p binding regions by replacing nt 2030-2036 (site A) and/or nt 2301-2308 (site B) with the sequence 5J9-CAG AAG GU-3′. All constructs were verified by DNA sequencing.
+ Open protocol
+ Expand
3

Luciferase Reporter Assay for Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Target plasmids were cloned into either the promoterless pGL4.10 firefly luciferase reporter vector (Promega) or the 3′UTR-less pmiR-Report firefly luciferase reporter vector (Ambion). Plasmids were co-transfected with the Renilla luciferase control reporter vector pRL-SV40 (Promega) in a fixed concentration (0.5 μg) to normalize for differences in transfection efficiencies. Cells were maintained in culture for at least 24 hrs after transfection and then processed using the Dual-Luciferase Reporter Assay System (Promega) according to manufacturer's recommendations. Luciferase levels were quantitated using a 20/20n luminometer (Promega). Data were expressed as the ratio of firefly luciferase (FL) to Renilla luciferase (RL) to normalize for differences in transfection efficiencies.
+ Open protocol
+ Expand
4

Dissecting Transcriptional Regulation of miR-944 and ΔNp63

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ΔNp63 and MIR944 promoter regions were amplified from human genomic DNA by PCR using the primer sets listed in Supplementary Table S3. PCR products were cloned into the pGL3-Basic vector (Promega, Madison, WI, USA). The mutant constructs were generated using the QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA), according to the manufacturer's instructions, using the primer sets listed in Supplementary Table S3. Human primary keratinocytes or WM266-4 melanoma cells were transfected with each of the constructed luciferase constructs. All cells were cotransfected with the β-galactosidase expression vector (pSV-β-galactosidase). ΔNp63 expression vectors were purchased from Addgene (Cambridge, MA, USA). TFAP2A and TFAP2C expression vectors were constructed with the primers listed in Supplementary Table S3.
Partial segments of the 3′ UTR of MAPK1, FGF2, NRAS, RRAS2 mRNA containing the predicted miR-944-binding sequences were PCR-amplified using the primers listed in Supplementary Table S3. The PCR products were cloned into the pMIR-REPORT Firefly Luciferase reporter vector (Ambion, Austin, TX, USA). Site-directed mutagenesis was performed by overlapping PCR the primers listed in Supplementary Table S3.
+ Open protocol
+ Expand
5

Characterization of UTR and Promoter Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Partial segments of the 3′-untranslated regions (UTRs) of the TYR, DCT and SH3BP4 mRNAs were subjected to PCR amplification using the primer sets shown in Supplementary Table 2. The obtained PCR products were cloned into the pMIR-REPORT Firefly Luciferase reporter vector (Ambion). SH3BP4 promoter regions with the predicted MITF binding sites were amplified from human genomic DNA by PCR using the primer sets listed in Supplementary Table 2. PCR products were cloned into the pGL3-Promoter vector (Promega, Madison, WI, USA). Mutant constructs were generated using a QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA), according to the manufacturer’s instructions, with the primer sets listed in Supplementary Table 2. WM266-4 cells were cotransfected with 200 ng of each 3′-UTR reporter construct and 100 ng of a β-galactosidase expression vector (internal control) by using Lipofectamine 3000 (Invitrogen). Luciferase and β-galactosidase activities were measured using a Luciferase Assay Kit (Promega) and Enhanced β-Galactosidase Assay kit (Gelantis, San Diego, CA, USA) according to the manufacturers’ protocols.
+ Open protocol
+ Expand
6

Cloning and Validation of 3′-UTR Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type 3′-UTR of HSP47 and LOX genes were PCR amplified from human genomic DNA using the primers listed in Table S1. The mutant 3′-UTR of HSP47 without putative miR-29b-binding sequence was also amplified. To clone the mutant 3′-UTR of LOX without the putative miR-29b binding sites, two fragments of LOX 3′-UTR were amplified separately and joined by overlap extension PCR according to a published method [23 (link)]. The PCR products of wild-type or mutant 3′-UTR for HSP47 were then cloned into the MluI-HindIII site downstream of the stop codon in the pMIR-REPORT Firefly Luciferase reporter vector (Ambion). The segments of wild-type or mutant 3′-UTR for LOX were cloned into the same vector at SacI-MluI site. The sequences of the generated constructs were confirmed by restriction digestion and sequencing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!